PharOS

Private

GreeceHealthcare & Life Scienceshttps://pharosgr.gr/

Last Round

Private Equity

Oct 24, 2024

Est. Valuation

$428M

Company Overview

PharOS is a pharmaceutical company that develops, manufactures, and supplies generic, over-the-counter, and value-added pharmaceutical products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Compliance, Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

generic medicinespharmaceutical developmentregulatory affairsCDMOcontract manufacturingpharmaceutical licensingpharmacovigilancepharma supply chaindossier preparationvalue-added medicinesdrug registrationpharma out-licensingOTC medicinespharma consultingdrug formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharOS Comps

Public and private peers based on sector, stage, and business model.

PharOS comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PharOS Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Oct 24, 2024
Private Equity	Aug 19, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Alexis Rizos

CFO

Executive Team

PharOS Investors

Notable investors and investment history

PharOS investors
Investor	Rounds
Viessmann Generations Group	Private Equity
Armira	Private Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 12, 2026
Grew 17% QoQ, from 318 to 372 employees.
Feb 28, 2025
Monthly visitors grew 162% MoM, reaching 2.3K.

View all signals

PharOS Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PharOS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharOS's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreece

Employee Range397

Year FoundedN/A

Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.